病理検査室の市場規模、シェア、動向分析レポート：タイプ別、検査サービス別、最終用途別、地域別、セグメント予測、2025年～2030年

病理検査室市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の病理検査室市場規模は2025年から2030年にかけてCAGR 8.1％を記録し、2030年には6,122億2,000万米ドルに達すると推定されています。

業界を牽引する主な要因としては、平均寿命の伸び、発展途上国におけるヘルスケアインフラの整備、償還の促進、定期検診需要の高まりなどが挙げられます。

さらに、技術の進歩が診断のダイナミクスを変化させています。革新的な技術により、POCT（Point of Care Testing）デバイスは携帯可能となり、サンプリング技術も改善されたため、診断サービスはより身近で効率的なものとなっています。いくつかの進歩は、品質、スピード、効率性、拡張性を通じて患者ケアの舵取りを行い、業界を変革すると期待されています。ヘルスケアシステムは、より迅速かつ正確に患者をモニターするだけでなく、推論や診断を行う上で医師を支援し、より大きな臨床的意思決定エンジンとなる病理・診断ラボの重要性を徐々に強調しています。

COVID-19のパンデミックは、COVID-19の検査がパンデミック中に必要であったため、病理・診断ラボに対する需要の増加をもたらしました。COVID-19感染の急増は、資金と検査の増加につながり、市場全体の成長を押し上げました。例えば、米国国立衛生研究所（NIH）は2020年9月、同地域の診断を強化するイニシアチブの一環として、COVID-19検査技術の新たなセットへの製造支援を拡大するため、Maxim Biomedical Inc.、MatMaCorp、MicroGEM Internationalなどを含む9団体に1億2,930万米ドルの資金を供与すると発表しました。

病理検査室市場レポートハイライト

• タイプ別では、病院ベースの診断ラボが2024年の市場を独占しました。これは、病院で利用可能な高度な検査が、複雑な診断のための唯一の最良のソリューションとなっていることに起因しています。
• 最終用途に基づくと、医師の紹介が2024年の市場を独占しました。ウォークインと法人顧客は、個人の健康とウェルネスをモニタリングするための自己認識の高まりにより、有利な成長が見込まれます。
• 米国は、米国で最も顕著な疾患の結果として、心血管健康の診断に対する高い需要が期待されます。
• 欧州は予測期間中に大きなCAGRが見込まれます。デンマークは、世界がん研究基金インターナショナルによると、がんの有病率が世界的に最も高いです。
• 同市場では最近、主要企業がサービスの付加価値向上と研究の拡大を目指し、複数の共同研究を実施しています。例えば、2022年7月、ユニラボはSubtle Medical社との提携を発表し、高品質かつ迅速なMRIのために同社のAIベースのMRI技術を採用する最初の診断企業となります。このソリューションはまずスウェーデンで開始されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 病理検査室市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 病理検査室市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 病理検査室市場：タイプの推定・動向分析

• セグメントダッシュボード
• 病理検査室市場：タイプ変動分析
• 病理検査室市場：タイプ別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 病院
• スタンドアロンラボ
• 診断専門

第5章 病理検査室市場：検査サービスの推定・動向分析

• セグメントダッシュボード
• 病理検査室市場：検査サービス変動分析
• 病理検査室市場：検査サービス別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 一般的な生理学的検査および臨床検査
• 画像検査および放射線検査
• 難解な検査
• COVID-19検査

第6章 病理検査室市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 病理検査室市場：最終用途変動分析
• 病理検査室市場：最終用途別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 医師の紹介
• ウォークイン
• 企業

第7章 病理検査室市場：地域の推定・動向分析

• 地域別ダッシュボード
• 市場規模、予測動向分析、2018年から2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 主要市場参入企業による最近の動向と影響分析
• 企業市場シェア分析、2024年
• 主要企業プロファイル
  • Quest Diagnostics Incorporated
  • Eurofins Scientific
  • Laboratory Corporation of America Holdings
  • Exact Sciences Laboratories LLC
  • Spectra Laboratories
  • SYNLAB International GmbH
  • Sonic Healthcare Limited
  • DR Lal Path Labs.
  • Metropolis Healthcare
  • Kingmed Diagnostics

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. Global Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 4. Global Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 5. Global Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 6. North America Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 7. North America Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 8. North America Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 9. U.S. Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 10. U.S. Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 11. U.S. Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 12. Canada Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 13. Canada Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 14. Canada Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 15. Mexico Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 16. Mexico Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 17. Mexico Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 18. Europe Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 19. Europe Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 20. Europe Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 21. UK Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 22. UK Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 23. UK Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 24. Germany Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 25. Germany Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 26. Germany Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 27. France Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 28. France Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 29. France Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 30. Italy Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 31. Italy Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 32. Italy Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 33. Spain Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 34. Spain Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 35. Spain Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 36. Denmark Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 37. Denmark Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 38. Denmark Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 39. Sweden Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 40. Sweden Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 41. Sweden Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 42. Norway Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 43. Norway Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 44. Norway Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 45. Asia Pacific Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 46. Asia Pacific Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 47. Asia Pacific Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 48. Japan Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 49. Japan Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 50. Japan Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 51. China Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 52. China Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 53. China Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 54. India Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 55. India Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 56. India Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 57. Australia Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 58. Australia Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 59. Australia Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 60. South Korea Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 61. South Korea Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 62. South Korea Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 63. Thailand Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 64. Thailand Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 65. Thailand Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 66. Latin America Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 67. Latin America Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 68. Latin America Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 69. Brazil Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 70. Brazil Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 71. Brazil Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 72. Argentina Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 73. Argentina Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 74. Argentina Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 75. Middle East & Africa Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 76. Middle East & Africa Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 77. Middle East & Africa Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 78. South Africa Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 79. South Africa Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 80. South Africa Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 81. Saudi Arabia Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 82. Saudi Arabia Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 83. Saudi Arabia Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 84. UAE Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 85. UAE Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 86. UAE Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
• Table 87. Kuwait Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
• Table 88. Kuwait Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
• Table 89. Kuwait Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information procurement
• Fig. 2 Primary research pattern
• Fig. 3 Market research approaches
• Fig. 4 Value chain-based sizing & forecasting
• Fig. 5 Market formulation & validation
• Fig. 6 Pathology Laboratories market segmentation
• Fig. 7 Market driver analysis (current & future impact)
• Fig. 8 Market restraint analysis (current & future impact)
• Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 10 Porter's five forces analysis
• Fig. 11 Pathology Laboratories market, Type outlook key takeaways 2024 & 2030 (USD Million)
• Fig. 12 Pathology Laboratories market, Testing Services outlook key takeaways 2024 & 2030 (USD Million)
• Fig. 13 Pathology Laboratories market, End-Use outlook key takeaways 2024 & 2030 (USD Million)
• Fig. 14 Hospital Based market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 Imaging Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 16 Respiratory Measurement Devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 17 Other Hospital Based market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 18 Standalone Labs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Diagnostic Chains market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 General Physiological & Clinical Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Imaging & Radiology Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Esoteric Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 COVID-19 Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Physician Referrals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Walk-ins market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Corporate market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 North America Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 US Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Canada Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Mexico Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Europe Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 UK Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Germany Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 France Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Spain Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Italy Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Norway Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Denmark Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Sweden Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Asia Pacific Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 China Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Japan Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 India Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 South Korea Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Australia Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Thailand Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Latin America Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Brazil Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Argentina Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Middle East and Africa Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 South Africa Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Saudi Arabia Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 UAE Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Kuwait Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 List of key emerging company's/Allergen disruptors/innovators

Pathology Laboratories Market Growth & Trends:

The global pathology laboratories market size is estimated to reach USD 612.22 billion by 2030, registering a CAGR of 8.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The major factors driving the industry include increasing life expectancy, the development of healthcare infrastructure in developing nations, favoring reimbursement, and rising demand for routine medical check-ups.

In addition, the advancement of technology is altering the dynamics of diagnosis. Innovative technologies have made Point of Care Testing(POCT) devices portable and improved sampling techniques, making diagnostic services more accessible and efficient. Several advancements are expected to transform the industry by steering patient care through quality, speed, efficiency, and scalability. The healthcare system is progressively emphasizing the importance of pathological & diagnostic labs in becoming a greater clinical decision-making engine, assisting physicians in making inferences and diagnosing as well as monitoring patients more quickly and accurately.

The COVID-19 pandemic has resulted in higher demand for pathology/diagnostic labs as the testing for COVID-19 was necessary during the pandemic. The rapid rise of COVID-19 infections has resulted in increased funding and testing, which has boosted the overall market growth. For instance, the (NIH) National Institutes of Health in the United States announced in September 2020 that it would grant USD 129.3 million in funding to nine organizations including, Maxim Biomedical Inc., MatMaCorp, MicroGEM International, & others, for scaling-up manufacturing assistance to a new set of COVID-19 testing technologies as component of its initiative to boost diagnostics in the region.

Pathology Laboratories Market Report Highlights:

• Based on type, hospital-based diagnostic labs dominated the market during the year 2024. This can be attributed to the advanced tests available at hospitals, making them the only best solution for complex diagnosis
• Based on the end use, physician referrals dominated the market in 2024. Walk-in and corporate clients are expected to witness lucrative growth due to increased self-awareness for monitoring health and wellness among individuals
• U.S. is expected to have a high demand for the diagnosis of cardiovascular health as a result of the most prominent disease in the U.S.
• Europe is expected to have a significant CAGR during the forecast period. Denmark has the highest prevalence of cancer globally in terms of cancer prevalence as per the World Cancer Research Fund International
• The market is witnessing multiple collaborations in recent times with the key players aiming at adding value to their services & expanding their research. For Instance, in July 2022, Unilabs announced a partnership with Subtle Medical, to be the first diagnostic company to adopt their AI-based MRI technology for high-quality & quick MRI. The solution will be first launched in Sweden.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Testing Services
  • 1.2.3. End Use
  • 1.2.4. Regional Scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Pathology Laboratories Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Improving healthcare infrastructure in developing countries
    • 3.2.1.2. Increasing demand for regular general health check-ups
    • 3.2.1.3. Gowning reimbursement for diagnostics services
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Affordability for high-end molecular diagnostics
    • 3.2.2.2. Shortage of skilled workforce
• 3.3. Pathology Laboratories Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Pathology Laboratories Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Pathology Laboratories Market: Type Movement Analysis
• 4.3. Pathology Laboratories Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Hospital Based
  • 4.5.1. Hospital Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Standalone Labs
  • 4.6.1. Standalone Labs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Diagnostic Chains
  • 4.7.1. Diagnostic Chains Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pathology Laboratories Market: Testing Services Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Pathology Laboratories Market: Testing Services Movement Analysis
• 5.3. Pathology Laboratories Market by Testing Services Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. General Physiological & Clinical Tests
  • 5.5.1. General Physiological & Clinical Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Imaging & Radiology Tests
  • 5.6.1. Imaging & Radiology Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Esoteric Tests
  • 5.7.1. Esoteric Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. COVID-19 Tests
  • 5.8.1. COVID-19 Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pathology Laboratories Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Pathology Laboratories Market: End Use Movement Analysis
• 6.3. Pathology Laboratories Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Physician Referrals
  • 6.5.1. Physician Referrals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Walk-Ins
  • 6.6.1. Walk-Ins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Corporate
  • 6.7.1. Corporate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pathology Laboratories Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Recent Developments & Impact Analysis by Key Market Participants
• 8.3. Company Market Share Analysis, 2024
• 8.4. Key Company Profiles
  • 8.4.1. Quest Diagnostics Incorporated
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Eurofins Scientific
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Laboratory Corporation of America Holdings
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Exact Sciences Laboratories LLC
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Spectra Laboratories
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. SYNLAB International GmbH
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Sonic Healthcare Limited
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. DR Lal Path Labs.
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Metropolis Healthcare
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Kingmed Diagnostics
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives